Compliance in a Rapidly Changing Cannabis Industry
The cannabis industry is facing a very fragmented regulatory landscape. Some countries have already adopted federal requirements, while others are still figuring out how the industry should be regulated. In some instances, state and local lawmakers have enacted cannabis product legislation. This on-demand webinar walks through the regulatory challenges facing the cannabis industry and how to prepare your company for future regulations.
What You'll Learn
- How a fragmented regulatory landscape — spanning federal, state, and local requirements — shapes compliance obligations for cannabis companies.
- The key industry challenges that make compliance difficult in a rapidly changing market.
- A practical regulations and compliance overview for companies operating in the cannabis space.
- Examples of FDA findings, and what they signal about regulatory expectations.
- How to position your organization to prepare for future regulations rather than react after the fact.
What the Session Covers
The discussion will include:
- Industry challenges
- Regulations and compliance overview
- Examples of FDA findings
Why this matters: In a market where the rules differ by country, state, and locality — and continue to shift — cannabis companies need compliance practices that can keep pace. USDM Life Sciences helps regulated organizations build durable quality, data, and validation foundations so they stay aligned as regulatory expectations evolve. Approaches like continuous compliance and strong data integrity practices help ensure the records behind your products hold up under regulatory scrutiny.
Watch the On-Demand Webinar
Register to watch this session on demand and hear USDM's regulatory compliance leaders walk through the cannabis industry's challenges, the regulatory and compliance landscape, and examples of FDA findings. Have questions about your own compliance program? Contact us to talk with our team.
About the Presenters
Joeseph Cassella, Director of Regulatory Compliance, USDM Life Sciences
Joe has over 20 years of experience in the Pharmaceutical, Biotech and Medical Device industries. His focus has been on the IT/Design/Application/Validation and delivery of systems across organizations. He has led projects that touch on most of the functions of the industry inclusive of IT Infrastructure, Research & Development, QA/QC, Manufacturing, Compliance, and Sales & Marketing. All while staying abreast of the changing regulatory environment.
Donald Zinn, Director of Emerging Compliance, USDM Life Sciences
Don provides validation and compliance leadership for USDM’s emerging clients with over 22 years of quality, compliance and systems validation experience. Don has experience working with various GXP organizations that provide services in the areas of blood banking, central laboratory testing, and clinical development. Don’s focus is assisting emerging clients in the Life Sciences industry to become compliant with best industry practices and regulatory guidelines while minimizing risk to patients and data.
FAQ: Cannabis Compliance and Regulation
Why is the cannabis regulatory landscape so fragmented?
Regulation of cannabis varies widely. Some countries have already adopted federal requirements while others are still determining how the industry should be regulated, and in some cases state and local lawmakers have enacted their own cannabis product legislation. That patchwork of federal, state, and local rules is what makes compliance complex for companies in the space.
What topics does this on-demand webinar cover?
The session covers the key industry challenges, a regulations and compliance overview, and examples of FDA findings — giving companies a grounded view of the expectations they need to meet.
How can a cannabis company prepare for future regulations?
Because the regulatory environment continues to change, companies benefit from a forward-looking compliance posture — understanding current requirements, learning from FDA findings, and building quality and validation practices that can adapt as the rules evolve. Validating the computerized systems that hold quality and product data, using approaches like Computer Software Assurance (CSA) and 21 CFR Part 11 compliance, helps ensure those records stand up to inspection.
Who should watch this webinar?
The session is aimed at companies operating in or entering the cannabis industry that need to understand the compliance challenges they face and how to align their practices with evolving regulatory oversight.
Who are the presenters?
The webinar is presented by Joeseph Cassella, Director of Regulatory Compliance at USDM Life Sciences, and Donald Zinn, Director of Emerging Compliance at USDM Life Sciences — both with extensive regulatory, quality, and systems validation experience across life sciences.
Navigate a Changing Regulatory Landscape with Confidence
USDM Life Sciences helps regulated companies build the quality, data, and compliance foundations that hold up as regulations evolve. Contact us to discuss how we can help your organization prepare for what's next.